Riviere P, Kanters C, Pellet G, Ni A, et al. Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease: A Retrospective Study From 2 Referral Centers. Inflamm Bowel Dis 2023;29:923-931.
PMID: 35917111